Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage

Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance

(2012) G Browne et al.   BRITISH JOURNAL OF CANCER

Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib

(2012) Ling Li et al.   CANCER CELL

The transcription factor CREBZF is a novel positive regulator of p53

(2012) Irene López-Mateo et al.   CELL CYCLE

Runt-related transcription factor 2 in human colon carcinoma: A potent prognostic factor associated with estrogen receptor

(2012) Tomohiko Sase et al.   INTERNATIONAL JOURNAL OF CANCER

Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis

(2012) Yang Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Runt-related Transcription Factor 1 (RUNX1) Stimulates Tumor Suppressor p53 Protein in Response to DNA Damage through Complex Formation and Acetylation

(2012) Dan Wu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer

(2012) Y-H Nicole Tsang et al.   ONCOGENE

RUNX3 Mediates Suppression of Tumor Growth and Metastasis of Human CCRCC by Regulating Cyclin Related Proteins and TIMP-1

(2012) Lijie He et al.   PLoS One

Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells

(2012) Lei Wang et al.   PLoS One

Genomic Promoter Occupancy of Runt-related Transcription Factor RUNX2 in Osteosarcoma Cells Identifies Genes Involved in Cell Adhesion and Motility

(2011) Margaretha van der Deen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy

(2010) Bekim Sadikovic et al.   BMC CANCER

Runx2 in human breast carcinoma: its potential roles in cancer progression

(2010) Yoshiaki Onodera et al.   CANCER SCIENCE

RUNX3 Modulates DNA Damage-mediated Phosphorylation of Tumor Suppressor p53 at Ser-15 and Acts as a Co-activator for p53

(2010) Chizu Yamada et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated Functions

(2010) Z. Yuan et al.   MOLECULAR AND CELLULAR BIOLOGY

Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents

(2010) M. Namdar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions

(2009) J Akech et al.   ONCOGENE

The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis

(2008) Y.-S. Lee et al.   CANCER RESEARCH

Expression and Function of Cbfa-1/Runx2 in Thyroid Papillary Carcinoma Cells

(2008) Toyoshi Endo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expression of RUNX3 Gene, Methylation Status and Clinicopathological Significance in Breast Cancer and Breast Cancer Cell Lines

(2008) Ying Jiang et al.   PATHOBIOLOGY